United Kingdom· GB-APID-40604811000001102
Brukinsa 80mg capsules
A zanubrutinib product containing zanubrutinib, registered in United Kingdom by BeOne Medicines UK Ltd. The same ATC class is registered in 15 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Zanubrutinib is registered in 15 of 19 countries.
Countries holding a registration under ATC L01EL03 (zanubrutinib), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Zanubrutinib · ATC L01EL03
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of zanubrutinib costs, country by country.
Normalised to the WHO defined daily dose (0.32 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Zanubrutinib · price per daily dose (0.32 g)
USD · FX 28 Sept 2026
- CH Switzerland$188.14
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Zanubrutinib
- Manufacturer
- BeOne Medicines UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01EL03
- ATC class
- Zanubrutinib
- Defined daily dose
- 0.32 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin08720598340044
- gtin08720598340440
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
217 interactions on record for zanubrutinib.
Graded by severity as the source publishes them — 140 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Zanubrutinib · interactions on record
217 records
- 140 severe
- 77 moderate
Most severe, free to view
- AprepitantA04AD12severe
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- HeparinB01AB01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Zanubrutinib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBRUKINSABeOne Medicines USA, Inc.
- SpainBRUKINSA 80 MG CAPSULAS DURASBeone Medicines Ireland Limited
- SwitzerlandBrukinsa
- CzechiaBRUKINSABeOne Medicines Ireland Limited, Dublin
- FinlandBRUKINSABeOne Medicines Ireland Limited
- FranceBRUKINSA 80 mg, géluleBEONE MEDICINES IRELAND (IRLANDE)
- BelgiumBrukinsa 80 mgBeOne Medicines Ireland
- IcelandBrukinsaBeone Medicines Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Brukinsa
- Norway · Brukinsa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/de7eca01-3905-422c-bb44-5fe37298f677 GET /v1/drugs/de7eca01-3905-422c-bb44-5fe37298f677?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "40604811000001102",
"desc": "Brukinsa 80mg capsules (BeOne Medicines UK Ltd)",
"form": "Oral capsule",
"vpid": "40689311000001106",
"source": "dmd",
"vtm_id": "830208008",
"strength": "80 mg",
"substance": "Zanubrutinib",
"ingredient": "Zanubrutinib",
"supplier_code": "40228811000001100"
}See everything about zanubrutinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.